Mehmet Müezzinoğlu, Minister of Health, visited Pharmactive factory that is one of the most important pharmaceutical production centre
Pharmactive, belonging to the Saya Group, one of the long-established companies in Turkey host Minister of Health Mehmet Müezzinoğlu in their production centre in Çerkezköy. After having toured the foundation and taking information from the management department Mehmet Müezzinoğlu stated that ‘’ we are very proud that such a well-equipped investment is being made in our country. I congratulate your excitement and vision. We are making some evaluations about support for domestic investors as Ministry of Health.’’ Pharmactive 1st Stage Foundation entered health sector as not only Turkey’s leading production foundation but also the leading production foundation in the world with its space taking 40.000 square meters. The company aims to be one of the most important 5 generic pharmaceutical firms in Turkey 5 years later since its opening with $ 300 billion endorsement. Mehmet Müezzinoğlu visited the foundation took the opportunity to understand their place in sector and listen to their problems and know closely the pharmaceutical production. Doctor Ekrem Atbakan, Deputy Secretary in Ministry of Health; Metin Kubilay, Çerkezköy Governor and Güven Artıran, Medication and Pharmaceutics Deputy General Manager accompanied Mehmet Müezzinoğlu, Minister of Health during the visit to the foundation in Çerkezköy.
INVESTMENT IN THE AMOUNT OF $120 MILLIONS
Saya Group, putting its signature under important work in building, energy and retail sector, transferred its experiences on medication distribution to medication production with Pharmactive. Pharmactive, with its first stage taking 40.000 square meters indoor area and the foundation in Çerkezköy invested in the amount of $120 Billion aims at involving in top 5 companies among Turkish Medication Production Companies in 5 years with the ‘’How happy the man is who remedies a trouble’’ motto. Total investment cost will be $200 million when all the stages are completed. The most important goal of Pharmactive is to be the first Turkish company working with its own sales and marketing equip and developing the medications with high added value like cancer, biotechnology, hormone, and inhaler products within its foundations in Turkey.
THE GOAL IS EXPORTATION TO USA
Abdulrezzak Sancak, Saya Group Chairman, emphasizes the importance of their company’s goals while touring the production foundation and stated that ‘’ we wish to proceed the success of our company’s services in the next years. One of our main goals is to export to USA with our own sales and marketing equip by taking the support of our previous success.’’
THE GOAL OF PHARMACTIVE IS TO PRODUCE MEDICATIONS WITH HIGH ADDED VALUE
Köksal Ülgen, Pharmactive General Manager, indicates that they are assertive in the sector and they are aiming to bring in something new with their research and development investments. He also said that they are planning to export the medications, which will be produced in the foundation with the capacity of 330 million boxes production for now, to the developed and developing markets like European countries and the USA. He lastly added that ‘’we, as a domestic company regarding the exportation as a strategic, are aiming to reach the sales in the amount of 50-100 million dollars. Particularly, we created a reason pushing the foreign companies to choose Turkey for their production foundation. We wish support for our projects related to exportation.’’ Pharmactive produces wide range of products serving various doctor groups such as gastroenterology, chest diseases, cardiology, and psychiatry in its own foundation. They, serving for Turkish Medicine with their 11 representative agencies, 350 medical representatives and its staff comprised of 700 workers in total, will employ more than 2000 people when all the stages are completed.